Financing ·
Jaguar Health, Inc. entered into several amendments to its royalty and debt obligations on June 17, 2026
JAGXJaguar Health, Inc.
Jaguar Health, Inc. entered into several amendments to its royalty and debt obligations on June 17, 2026. The company amended its Uptown 2020 and Streeterville 2022 royalty interests to establish a minimum monthly payment of $750,000 starting October 1, 2026. Additionally, a $6,220,812.50 secured promissory note held by its subsidiary, Napo Pharmaceuticals, Inc., was extended to a new maturity date of October 1, 2026. The company also executed three private exchange agreements with Streeterville Capital, LLC between June 9 and June 18, 2026, issuing a total of 109,249 shares of common stock to retire 10.88 shares of Series Q Perpetual Preferred Stock. Jaguar Health, Inc. is a healthcare company focused on gastrointestinal health products.